# A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease

> **NCT03112096** · PHASE1 · COMPLETED · sponsor: **Asan Foundation** · enrollment: 12 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** [18F]THK-5351

## Key facts

- **NCT ID:** NCT03112096
- **Lead sponsor:** Asan Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-17
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-08-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03112096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03112096, "A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03112096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*